Clinical Trials Browser

Phase NA × Triple Negative Breast Neoplasms × 130-nm albumin-bound paclitaxel × Clear all

NCT06975644 2025-05-22

Evaluating Bemotuzumab to Improve the Efficacy of Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer (TNBC)

Phase NA Not yet recruiting

Triple Negative Breast Neoplasms